Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lifeward Ltd. - Ordinary Shares (NQ:LFWD)

0.7749 -0.0384 (-4.72%)
Streaming Delayed Price Updated: 10:12 AM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lifeward Ltd. - Ordinary Shares

< Previous 1 2 Next >
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
Seventh generation of industry-leading ReWalk Exoskeleton is now cleared for commercial launch in the European Union 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Ltd. Reports Second Quarter 2025 Financial Results
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership
From Lifeward Ltd.
Via GlobeNewswire
Lifeward to Report Second Quarter Financial Results on August 14, 2025
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
Expansion adds additional AlterG dealer coverage to 6 countries throughout the Gulf Cooperation Council region 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Announces Closing of $2.6 Million Public Offering
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Announces Pricing of $2.6 Million Public Offering
From Lifeward Ltd.
Via GlobeNewswire
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
Decision at the highest levels of appeal in the Medicare process establishes medical necessity of the ReWalk Exoskeleton for enabling paralyzed individuals to stand and walk in everyday environments. 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Names Mark Grant as New CEO
Industry veteran brings 30 years of commercial leadership experience 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward to Present at Sidoti Virtual Investor Conference on May 21
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Ltd. Reports First Quarter 2025 Financial Results
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
Three-year program examined opportunities to integrate artificial intelligence technology into future generations of ReWalk Exoskeletons 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025
From Lifeward Ltd.
Via GlobeNewswire
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
From Lifeward Ltd.
Via GlobeNewswire
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton
Cooperation between Lifeward and Beilinson Hospital marks the first step towards a national policy in Israel on Exoskeleton training and procurement 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
From Lifeward Ltd.
Via GlobeNewswire
FDA Issues Clearance for ReWalk 7 Exoskeleton
Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
From Lifeward Ltd.
Via GlobeNewswire
Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton
From Lifeward Ltd.
Via GlobeNewswire
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
New Agreement Expands Distribution Rights to Lifeward to Include Referral Sales for Home Use Applications 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Announces CEO Transition
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany
From Lifeward Ltd.
Via GlobeNewswire
Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025
From Lifeward Ltd.
Via GlobeNewswire
Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities
With recent financing and current capital, the Company believes it has sufficient cash to pursue its goals 
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Cancels Its Extraordinary General Meeting of Shareholders
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders
From Lifeward Ltd.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.